Rising Concerns: Surge in Gastric Outlet Obstruction Cases Linked to Drug Abuse

Written By : Dr.Niharika Harsha B |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-01-20T06:00:46+05:30 | Updated On 20 Jan 2024 4:08 PM IST

In a stark and alarming trend, a medical center in India has witnessed a significant upswing in cases of gastric outlet obstruction (GOO) with drug abuse, emerging as a prominent contributing factor. The urgency to address this concerning surge prompted an observational study, conducted from September 2017 to February 2019, to delve into the incidence of abuse involving nonsteroidal anti-inflammatory drugs (NSAIDs) and synthetic opioids among individuals diagnosed with GOO.

The study was published in the Journal of the Association of Physicians of India.

Also Read: Opioids or NSAIDs- Which are safer and more effective for treating pain after surgery in youth

The research, involving consecutive cases of GOO, aimed to comprehensively understand the extent of drug abuse's role in this debilitating condition. Each case underwent a thorough examination, including detailed drug addiction histories and clinical assessments. Diagnostic investigations spanned routine biochemical and hematological tests, upper gastrointestinal endoscopy (UGIE), ultrasonography, rapid urease test (RUT), and meticulous histopathological analysis of the affected areas.

Findings:

Out of the 102 diagnosed cases of GOO, a staggering 60.78% (62 cases) had a documented history of drug addiction.
Further breaking down the drug addiction patterns revealed a prevalence of combined NSAIDs and opioid abuse in 56 cases, opioids alone in four cases, and NSAIDs alone in two cases.
Intriguingly, the second part of the duodenum emerged as the most commonly affected site, underscoring the severity and complexity of these cases.
Histopathological examinations offered deeper insights, uncovering mucosal ulcerations infiltrated by eosinophils, plasma cells, and lymphocytes.

The study's revelations point towards a pressing issue within our community – the growing incidence of GOO linked to the abuse of NSAIDs and opioids. It is not merely a statistical concern but a human concern, reflecting the real impact on individuals' lives. The high prevalence of drug addiction histories among diagnosed cases raises urgent red flags, prompting healthcare professionals and policymakers alike to consider immediate and targeted interventions.

Also Read: Allopurinol initiation generally safe among gout patients on colchicine or NSAID for prophylaxis

The findings underscore the need for concerted efforts to control the indiscriminate use of over-the-counter drugs, particularly NSAIDs and opioids. The complications observed in these cases serve as a poignant reminder of the potentially severe consequences associated with unchecked drug abuse. This calls for a collaborative approach, involving healthcare practitioners, policymakers, and the community, to implement preventive measures, raise awareness, and curb the alarming trend of GOO linked to substance abuse.

Further reading: Joshi A, Falodia S, Vyas A, et al. Alarming Incidence of Gastric Outlet Obstruction Related to NSAIDS and Synthetic Opioid in North West India. J Assoc Physicians India 2024;72(1):14–16.DOI: 10.59556/japi.71.0432

gastric outlet obstructionNSAIDSJournal of the Association of Physicians in IndiaJAPIAshish JoshiNSAIDs

Source : Journal of the Association of Physicians of India.

Dr.Niharika Harsha B

BDS, MDS

Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751